FDA Rejects Proposed Xarelto Antidote
Filed in: Xarelto Tags: xarelto antidote
References
Antidote treatments for the reversal of direct oral anticoagulants. (2015, June 23). Retrieved from https://www.cadth.ca/antidote-treatments-reversal-direct-oral-anticoagulants
O'Rierdan, M. (2016, August 18). FDA declines to approve portola's reversal agent for factor xa inhibitors. Retrieved from https://www.tctmd.com/news/fda-declines-approve-portolas-reversal-agent-factor-xa-inhibitors
Seigal, D. M., Curnutte, J. T., Connolly, S. J., Lu, G., Conley, P. B., Wiens, B. L., . . . Crowther, M. A. (2015, December 17). Andexanet alfa for the reversal of factor xa inhibitor activity — NEJM. Retrieved from http://www.nejm.org/doi/full/10.1056/NEJMoa1510991#t=article